Literature DB >> 7607254

Carbohydrate-deficient glycoprotein syndrome type II. An autosomal recessive N-acetylglucosaminyltransferase II deficiency different from typical hereditary erythroblastic multinuclearity, with a positive acidified-serum lysis test (HEMPAS).

J H Charuk1, J Tan, M Bernardini, S Haddad, R A Reithmeier, J Jaeken, H Schachter.   

Abstract

Carbohydrate-deficient glycoprotein syndromes (CDGS) are a family of multisystemic congenital diseases resulting in underglycosylated glycoproteins, suggesting defective N-glycan assembly. Fibroblast extracts from two patients with a recently described variant of this disease (CDGS type II) have previously been shown to have over 98% reduced activity of UDP-GlcNAc:alpha-6-D-mannoside beta-1,2-N-acetylglucosaminyltransferase II [GlcNAc-TII; Jaeken, J., Schachter, H., Carchon, H., De Cock, P., Coddeville, B. & Spik, G. (1994) Arch. Dis. Childhood 71, 123-127]. We show in this paper that mononuclear cell extracts from one of these CDGS type-II patients have no detectable GlcNAc-TII activity and that similar extracts from 12 blood relatives of the patient, including his father, mother and brother, have GlcNAc-TII levels 32-67% that of normal levels (average 50.1% +/- 10.7% SD), consistent with an autosomal recessive disease. The poly(N-acetyllactosamine) content of erythrocyte membrane glycoproteins bands 3 and 4.5 of this CDGS patient were estimated, by tomato lectin blotting, to be reduced by 50% relative to samples obtained from blood relatives and normal controls. Similar to patients with hereditary erythroblastic multinuclearity with a positive acidified-serum lysis test (HEMPAS), erythrocyte membrane glycoproteins in the CDGS patient have increased reactivities with concanavalin A, demonstrating the presence of hybrid or oligomannose carbohydrate structures. However, bands 3 and 4.5 in HEMPAS erythrocytes have almost complete lack of poly(N-acetyllactosamine). Furthermore, CDGS type-II patients have a totally different clinical presentation and their erythrocytes do not show the serology typical of HEMPAS, suggesting that the genetic lesions responsible for these two diseases are possibly different.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7607254     DOI: 10.1111/j.1432-1033.1995.0797h.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  15 in total

Review 1.  Recent progress in the molecular biology of the cloned N-acetylglucosaminyltransferases.

Authors:  N Taniguchi; Y Ihara
Journal:  Glycoconj J       Date:  1995-12       Impact factor: 2.916

2.  Regulation of expression of the human beta-1,2-N-acetylglucosaminyltransferase II gene (MGAT2) by Ets transcription factors.

Authors:  W Zhang; L Revers; M Pierce; H Schachter
Journal:  Biochem J       Date:  2000-04-15       Impact factor: 3.857

3.  Transcriptional regulation of the human UDP-GlcNAc:alpha-6-D-mannoside beta-1-2-N-acetylglucosaminyltransferase II gene (MGAT2) which controls complex N-glycan synthesis.

Authors:  S H Chen; S Zhou; J Tan; H Schachter
Journal:  Glycoconj J       Date:  1998-03       Impact factor: 2.916

4.  Determination of glycan structures and molecular masses of the glycovariants of serum transferrin from a patient with carbohydrate deficient syndrome type II.

Authors:  B Coddeville; H Carchon; J Jaeken; G Briand; G Spik
Journal:  Glycoconj J       Date:  1998-03       Impact factor: 2.916

5.  Congenital disorders of glycosylation type Ia and IIa are associated with different primary haemostatic complications.

Authors:  C Van Geet; J Jaeken; K Freson; T Lenaerts; J Arnout; J Vermylen; M F Hoylaerts
Journal:  J Inherit Metab Dis       Date:  2001-08       Impact factor: 4.982

Review 6.  Mass spectrometry of transferrin and apolipoprotein C-III for diagnosis and screening of congenital disorder of glycosylation.

Authors:  Yoshinao Wada
Journal:  Glycoconj J       Date:  2016-02-13       Impact factor: 2.916

Review 7.  The joys of HexNAc. The synthesis and function of N- and O-glycan branches.

Authors:  H Schachter
Journal:  Glycoconj J       Date:  2000 Jul-Sep       Impact factor: 2.916

8.  Caenorhabditis elegans triple null mutant lacking UDP-N-acetyl-D-glucosamine:alpha-3-D-mannoside beta1,2-N-acetylglucosaminyltransferase I.

Authors:  Shaoxian Zhu; Andrew Hanneman; Vernon N Reinhold; Andrew M Spence; Harry Schachter
Journal:  Biochem J       Date:  2004-09-15       Impact factor: 3.857

9.  Two closely related forms of UDP-GlcNAc: alpha6-D-mannoside beta1,2-N-acetylglucosaminyltransferase II occur in the clawed frog Xenopus laevis.

Authors:  Jan Mucha; Barbara Svoboda; Sonja Kappel; Richard Strasser; Peter Bencur; Ulrike Fröhwein; Harry Schachter; Lukas Mach; Josef Glössl
Journal:  Glycoconj J       Date:  2002-03       Impact factor: 2.916

Review 10.  The congenital disorders of glycosylation: a multifaceted group of syndromes.

Authors:  Erik A Eklund; Hudson H Freeze
Journal:  NeuroRx       Date:  2006-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.